/Companies

Cydex Pharmaceuticals Inc

Founded 1987 · 1 known investors

Find your way into Cydex Pharmaceuticals Inc

Sign up to see every warm intro you have to Cydex Pharmaceuticals Inc

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cydex Pharmaceuticals Inc team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Captisol is a pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), a derivatized beta cyclodextrin used to solubilize and stabilize difficult-to-deliver molecules across routes such as parenteral, oral, ophthalmic, nasal, and inhalation. Made by CyDex Pharmaceuticals (a Ligand company), it is used in approved therapeutics including remdesivir and carfilzomib, and is also explored for consumer health, supplements, and personal care products.

Investors · 1

Related companies · 2

Companies working in the same space as Cydex Pharmaceuticals Inc.

Frequently asked questions

What does Cydex Pharmaceuticals Inc do?
Captisol is a pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), a derivatized beta cyclodextrin used to solubilize and stabilize difficult-to-deliver molecules across routes such as parenteral, oral, ophthalmic, nasal, and inhalation. Made by CyDex Pharmaceuticals (a Ligand company), it is used in approved therapeutics including remdesivir and carfilzomib, and is also explored for consumer health, supplements, and personal care products.
Who are Cydex Pharmaceuticals Inc's investors?
Cydex Pharmaceuticals Inc's investors include RiverVest Venture Partners.